American Superconductor (AMSC) Reaches $4.06 After 9.00% Down Move; Sorrento Therapeutics (SRNE) Shorts Lowered By 15.18%

May 30, 2017 - By Richard Conner

The stock of American Superconductor Corporation (NASDAQ:AMSC) is a huge mover today! About 142,807 shares traded. American Superconductor Corporation (NASDAQ:AMSC) has declined 61.56% since May 30, 2016 and is downtrending. It has underperformed by 78.26% the S&P500.The move comes after 6 months negative chart setup for the $74.04M company. It was reported on May, 30 by Barchart.com. We have $3.69 PT which if reached, will make NASDAQ:AMSC worth $6.66M less.

Sorrento Therapeutics Incorporated (NASDAQ:SRNE) had a decrease of 15.18% in short interest. SRNE’s SI was 3.16 million shares in May as released by FINRA. Its down 15.18% from 3.72 million shares previously. With 2.36M avg volume, 1 days are for Sorrento Therapeutics Incorporated (NASDAQ:SRNE)’s short sellers to cover SRNE’s short positions. The SI to Sorrento Therapeutics Incorporated’s float is 9.87%. About 206,567 shares traded. Sorrento Therapeutics Inc (NASDAQ:SRNE) has declined 73.31% since May 30, 2016 and is downtrending. It has underperformed by 90.01% the S&P500.

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The company has market cap of $129.79 million. The Firm is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. It currently has negative earnings. The Company’s primary therapeutic focus is oncology, including the treatment of chronic cancer pain.

Among 7 analysts covering Sorrento Therapeutics (NASDAQ:SRNE), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Sorrento Therapeutics had 9 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was initiated by FBR Capital with “Outperform” on Tuesday, December 22. Rodman & Renshaw reinitiated it with “Buy” rating and $45.0 target in Monday, December 7 report. The stock has “Buy” rating by Brean Capital on Wednesday, July 29. The stock has “Buy” rating by MLV on Monday, August 3. The company was initiated on Monday, December 7 by H.C. Wainwright. Rodman & Renshaw maintained Sorrento Therapeutics Inc (NASDAQ:SRNE) on Tuesday, April 5 with “Buy” rating. The rating was initiated by TH Capital with “Buy” on Monday, October 3. The stock of Sorrento Therapeutics Inc (NASDAQ:SRNE) has “Buy” rating given on Wednesday, November 25 by rean. The company was maintained on Wednesday, November 25 by Brean Capital.

Since February 3, 2017, it had 8 buys, and 1 sale for $88,450 activity. Shares for $20,600 were bought by Su Jeffrey. Ji Henry bought $103,000 worth of stock. $51,500 worth of Sorrento Therapeutics Inc (NASDAQ:SRNE) was bought by ZELDIS JEROME B. SHAH JAISIM bought $51,500 worth of Sorrento Therapeutics Inc (NASDAQ:SRNE) on Friday, February 3. Another trade for 5,000 shares valued at $25,750 was bought by Wu Yue Alexander. 3,000 shares were bought by Janda Kim, worth $15,450 on Friday, February 3. 40,000 shares were sold by Ng George K, worth $206,000 on Friday, February 3.

Investors sentiment increased to 1.38 in 2016 Q4. Its up 0.62, from 0.76 in 2016Q3. It increased, as 5 investors sold Sorrento Therapeutics Inc shares while 16 reduced holdings. 11 funds opened positions while 18 raised stakes. 13.14 million shares or 3.55% more from 12.69 million shares in 2016Q3 were reported. Wells Fargo & Mn has invested 0% in Sorrento Therapeutics Inc (NASDAQ:SRNE). American Intl Group Inc reported 0% in Sorrento Therapeutics Inc (NASDAQ:SRNE). California Public Employees Retirement Systems holds 38,400 shares or 0% of its portfolio. 28,600 are held by Creative Planning. Nationwide Fund Advisors holds 0% or 16,454 shares in its portfolio. Gsa Cap Prtn Ltd Liability Partnership, United Kingdom-based fund reported 17,019 shares. Commonwealth Of Pennsylvania School Empls Retrmt System reported 96,154 shares. Tiaa Cref Inv Mgmt Limited Company holds 0% in Sorrento Therapeutics Inc (NASDAQ:SRNE) or 109,818 shares. First Republic Inv Management Incorporated invested in 0% or 10,000 shares. Gofen Glossberg Limited Company Il holds 10,000 shares or 0% of its portfolio. Swiss Retail Bank reported 0% in Sorrento Therapeutics Inc (NASDAQ:SRNE). 1,996 were accumulated by Blackrock. State Street holds 0% or 514,597 shares in its portfolio. The Ontario – Canada-based Manufacturers Life Insur Co The has invested 0% in Sorrento Therapeutics Inc (NASDAQ:SRNE). Glenmede Tru Na has 29,135 shares for 0% of their portfolio.

American Superconductor Corporation is a well-known provider of megawatt-scale solutions. The company has market cap of $74.04 million. The Firm operates through two divisions: Wind and Grid. It currently has negative earnings. Through the Company’s Windtec Solutions brand, the Wind business segment enables manufacturers to field wind turbines.

Among 5 analysts covering American Superconductor (NASDAQ:AMSC), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. American Superconductor had 7 analyst reports since January 13, 2016 according to SRatingsIntel. FBR Capital initiated the stock with “Outperform” rating in Thursday, May 19 report. FBR Capital maintained American Superconductor Corporation (NASDAQ:AMSC) rating on Friday, May 26. FBR Capital has “Buy” rating and $900 target. The firm has “Buy” rating by H.C. Wainwright given on Friday, May 26. The rating was initiated by Oppenheimer with “Outperform” on Tuesday, June 21. The firm has “Buy” rating by Rodman & Renshaw given on Wednesday, January 13. Roth Capital maintained the shares of AMSC in report on Thursday, May 25 with “Buy” rating. The rating was initiated by H.C. Wainwright on Wednesday, January 13 with “Buy”.